Compass Point downgraded Genworth Financial (NYSE:GNW) from Buy to Neutral in a report released today.
- Updated: September 19, 2016
Compass Point has downgraded Genworth Financial(NYSE:GNW) from Buy to Neutral in a report released on Monday September 19 2016.
Having a price of $4.96, Genworth Financial (NYSE:GNW) traded 0.00% even on the day. The last close is up 51.27% from the 200-day average, compared to the S&P 500 which has fallen -0.01% over the date range. Genworth Financial has recorded a 50-day average of $3.96 and 200-day moving average of $3.28. 23,472 shares of the stock exchanged hands, down from ann avg. volume of 8,718,930
See Graphic Below:
With a total market value of $0.0, Genworth Financial has a 52 week low of $1.57 and a one-year high of $5.75 with a PE ratio of 0.
Also covering Genworth Financial’s price target, a total of 8 equity analysts have released a research note on the company. The average target price is $3.66 with two firms rating the company a strong buy, one firm rating the stock a buy, seven analyts rating the stock a hold, one brokerage rating the company to underperform, and lastly 0 firmsrating the company as sell.
Brief Synopsis On Genworth Financial (NYSE:GNW)
Genworth Financial, Inc. provides mortgage insurance products. The Company operates through five segments: U.S. Mortgage Insurance, Canada Mortgage Insurance, Australia Mortgage Insurance, U.S. Life Insurance and Runoff. Its U.S. Mortgage Insurance offers mortgage insurance products insuring prime-based, individually underwritten residential mortgage loans in the United States. Its Canada Mortgage Insurance segment offers flow mortgage insurance and also provides bulk mortgage insurance that aids in the sale of mortgages to the capital markets and helps lenders manage capital and risk in Canada. Its Australia Mortgage Insurance segment offers flow mortgage insurance and provides bulk mortgage insurance in Australia. Its U.S. Life Insurance offers long-term care insurance products in the United States. Its Runoff segment includes the results of non-strategic products, and which are no longer sold.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.